In short
Diabetic microvascular dysfunction encompasses the small vessel complications of long-term diabetes: peripheral neuropathy (nerve damage producing pain, tingling, and numbness), nephropathy (kidney damage), retinopathy (retinal vessel damage affecting vision), and impaired peripheral circulation producing poor wound healing and foot complications. At CLCC, care for diabetic microvascular dysfunction follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Diabetic microvascular complications are the long-term consequences of a metabolic environment that has not been adequately addressed.
Diabetic microvascular dysfunction encompasses the small vessel complications of long-term diabetes: peripheral neuropathy (nerve damage producing pain, tingling, and numbness), nephropathy (kidney damage), retinopathy (retinal vessel damage affecting vision), and impaired peripheral circulation producing poor wound healing and foot complications. These complications develop when sustained elevated blood sugar and advanced glycation end-products (AGEs) damage the small blood vessels and nerves throughout the body.
Standard management focuses on glycaemic control, reducing blood sugar to slow further damage. This is essential and appropriate. But what glycaemic control does not address is the oxidative stress that is driving microvascular damage independently of blood sugar levels, the mitochondrial dysfunction in nerve cells that impairs their survival and function, and the specific nutritional deficiencies, alpha-lipoic acid, B vitamins, vitamin D, CoQ10, that directly affect nerve and vascular cell health. CLCC addresses these alongside, not instead of, specialist diabetes and nephrology management.
Symptoms & Presentation
How this condition presents clinically.
Peripheral neuropathy, tingling, burning, numbness, or pain in the feet and legs
Impaired wound healing, cuts and abrasions on the feet healing slowly
Cold feet with poor circulation, peripheral arterial involvement
Postural dizziness, autonomic neuropathy affecting blood pressure regulation
Visual changes from retinopathy, floaters, blurred vision, or visual field changes (specialist assessment required)
Reduced sensation in the feet, inability to feel pain or temperature changes
Nephropathy indicators, microalbuminuria on urine testing
Increased susceptibility to foot infections from impaired healing and reduced sensation
Contributing Factors
What drives and sustains this condition.
Sustained hyperglycaemia and glycation
Elevated blood sugar produces advanced glycation end-products (AGEs) that directly damage vessel walls, nerve myelin, and filtration membrane proteins, driving microvascular complications independently of insulin levels.
Oxidative stress
Diabetic microvascular damage is mediated substantially through reactive oxygen species that overwhelm the antioxidant capacity of nerve and vessel cells. Alpha-lipoic acid and CoQ10 directly address this oxidative mechanism.
Mitochondrial dysfunction in neural tissue
Peripheral nerves depend on high mitochondrial energy production for axonal transport and maintenance. Mitochondrial dysfunction from CoQ10 and B vitamin depletion impairs nerve cell survival and repair, directly contributing to neuropathy progression.
B vitamin deficiency, particularly B12
Metformin use, extremely common in type 2 diabetes, reduces B12 absorption. B12 deficiency compounds diabetic neuropathy through impaired myelin production and nerve function. This is among the most common and most correctable contributors to diabetic neuropathy.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Assess microvascular markers, nutritional status, and oxidative stress alongside metabolic control
HbA1c and fasting insulin for metabolic assessment. Renal function and microalbuminuria. B12, folate, and vitamin D for neurological support. CoQ10 and alpha-lipoic acid status. Peripheral neuropathy scoring and foot examination findings. Retinal assessment history reviewed. Metformin dose and duration documented for B12 depletion assessment.
Identify the dominant microvascular mechanism, glycation, oxidative, mitochondrial, or nutritional
B12-driven neuropathy responds rapidly to B12 correction. Oxidative-driven damage responds to alpha-lipoic acid and antioxidant protocol. Mitochondrial dysfunction responds to CoQ10 and B vitamin complex. The assessment identifies the most addressable contributors.
Targeted neurological and vascular protection alongside metabolic optimisation
Alpha-lipoic acid at therapeutic doses for nerve and vascular antioxidant protection. B12 and B vitamin complex for nerve function and myelin support, particularly critical in metformin users. CoQ10 for mitochondrial nerve cell support. Vitamin D for immune and nerve health. Metabolic optimisation to reduce AGE formation. Foot care guidance and physical activity staging appropriate to neuropathy severity.
Track neuropathy symptoms, metabolic markers, and renal function at 3-month intervals
Neuropathy symptom scoring reviewed monthly. HbA1c and metabolic panel at 3 months. Renal function and microalbuminuria at 6 months. B12 and vitamin D levels rechecked at 3 months. Protocol refined based on symptom and marker response.
Long-term neuropathy and vascular protection, diabetic complications require sustained management
Microvascular damage progresses when the oxidative and metabolic environment remains unaddressed. The Continue phase maintains targeted nutritional supplementation, metabolic monitoring, and foot health vigilance, slowing progression and maintaining the function improvements achieved.
FAQs
Common questions about care.
Can diabetic neuropathy improve?+
Yes, particularly B12 deficiency neuropathy, which is common in metformin users and often substantially reversible with B12 correction. Oxidative neuropathy helps improve with alpha-lipoic acid supplementation at therapeutic doses. The degree of improvement depends on how long neuropathy has been established and how comprehensively the contributing factors are addressed. Early intervention produces better outcomes than late intervention.
Does CLCC replace diabetes specialist care for complications?+
No. Diabetic retinopathy requires ophthalmology assessment. Nephropathy requires nephrology involvement. Severe peripheral arterial disease requires vascular surgery assessment. CLCC addresses the nutritional, metabolic, and oxidative dimensions of microvascular complications that specialist care cannot, and works alongside specialist management, not instead of it.